Novartis' Dementia Patch Patent Suit Gets Booted
Novartis Pharmaceutical Corp. suffered a defeat Friday in its patent suit against generic-drug maker Zydus Noveltech Inc. over the Exelon dementia treatment patch, when a Delaware federal judge dismissed the case...To view the full article, register now.
Already a subscriber? Click here to view full article